Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Kalaris Therapeutics, Inc., Common Stock

KLRS

NMQ

$2.96

+$0.06

(2.07%)

Industry: Biotechnology Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$52.93M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

18.21K

Avg Volume

This is the average number of shares traded during the most recent 30 days.

Dividend Yield

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$2.65 L

$24.15 H

$2.96

About Kalaris Therapeutics, Inc., Common Stock

Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California. more

Industry: BiotechnologySector: Health Care

Returns

Time Frame	KLRS	Sector	S&P500
1-Week Return	4.59%	0.71%	0.79%
1-Month Return	-57.1%	-5.6%	6.04%
3-Month Return	-69.8%	-11.72%	-1.11%
6-Month Return	-76.52%	-10.81%	-2.39%
1-Year Return	-82.61%	-7.12%	11.69%
3-Year Return	-96.67%	-0.57%	42.29%
5-Year Return	-99.49%	27.64%	93.12%

Time Frame	KLRS	Sector	S&P500
1-Week Return	938.18%	44.62%	50.73%
1-Month Return	-100.00%	-50.40%	104.12%
3-Month Return	-99.22%	-39.68%	-4.43%
6-Month Return	-94.70%	-20.70%	-4.79%
1-Year Return	-82.61%	-7.12%	11.69%
3-Year Return	-67.83%	-0.19%	12.48%
5-Year Return	-65.21%	5.00%	14.07%

Financials

	Dec '22	Dec '23
Total Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	14.01M	13.46M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.13,"profit":true}]
Operating Income	(14.01M)	(13.46M)	[{"date":"2022-12-31","value":-1400600000,"profit":false},{"date":"2023-12-31","value":-1346400000,"profit":false}]
Total Non-Operating Income/Expense	(1.71M)	(1.92M)	[{"date":"2022-12-31","value":-171400000,"profit":false},{"date":"2023-12-31","value":-192200000,"profit":false}]
Pre-Tax Income	(15.48M)	(14.70M)	[{"date":"2022-12-31","value":-1548500000,"profit":false},{"date":"2023-12-31","value":-1469900000,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(15.48M)	(14.70M)	[{"date":"2022-12-31","value":-1548500000,"profit":false},{"date":"2023-12-31","value":-1469900000,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(15.48M)	(14.70M)	[{"date":"2022-12-31","value":-1548500000,"profit":false},{"date":"2023-12-31","value":-1469900000,"profit":false}]

EPS (Diluted)	(52.50)	(42.14)	[{"date":"2022-12-31","value":-5250.38,"profit":false},{"date":"2023-12-31","value":-4214.25,"profit":false}]

	Dec '22	Dec '23
Total Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	-	(3.87%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Operating Income	-	(3.87%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Non-Operating Income/Expense	-	12.14%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	-	(5.08%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(5.08%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(5.08%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

EPS (Diluted)	-	(19.73%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

	Dec '23	Mar '24	Mar '25
Total Revenue	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Cost of Revenue	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Gross Profit	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Gross Margin	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Operating Expenses	3.46M	2.56M	10.35M	[{"date":"2023-12-31","value":33.46,"profit":true},{"date":"2024-03-31","value":24.75,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Operating Income	(3.46M)	(2.56M)	(10.35M)	[{"date":"2023-12-31","value":-346400000,"profit":false},{"date":"2024-03-31","value":-256300000,"profit":false},{"date":"2025-03-31","value":-1035400000,"profit":false}]
Total Non-Operating Income/Expense	(46.00K)	(844.00K)	158.00K	[{"date":"2023-12-31","value":-29.11,"profit":false},{"date":"2024-03-31","value":-534.18,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Pre-Tax Income	(3.47M)	(3.41M)	(10.20M)	[{"date":"2023-12-31","value":-347100000,"profit":false},{"date":"2024-03-31","value":-340700000,"profit":false},{"date":"2025-03-31","value":-1019600000,"profit":false}]
Income Taxes	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Income From Continuous Operations	(3.47M)	(3.41M)	(10.20M)	[{"date":"2023-12-31","value":-347100000,"profit":false},{"date":"2024-03-31","value":-340700000,"profit":false},{"date":"2025-03-31","value":-1019600000,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income	(3.47M)	(3.41M)	(10.20M)	[{"date":"2023-12-31","value":-347100000,"profit":false},{"date":"2024-03-31","value":-340700000,"profit":false},{"date":"2025-03-31","value":-1019600000,"profit":false}]

EPS (Diluted)	(12.05)	(6.08)	(2.52)	[{"date":"2023-12-31","value":-1204.75,"profit":false},{"date":"2024-03-31","value":-607.61,"profit":false},{"date":"2025-03-31","value":-251.56,"profit":false}]

	Dec '23	Mar '24	Mar '25
Total Revenue	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Cost of Revenue	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Gross Profit	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Gross Margin	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Operating Expenses	-	(26.01%)	303.98%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":-8.56,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Operating Income	-	(26.01%)	303.98%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":-8.56,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	1734.78%	(118.72%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-6.84,"profit":false}]
Pre-Tax Income	-	(1.84%)	199.27%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":-0.93,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Income Taxes	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Income From Continuous Operations	-	(1.84%)	199.27%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":-0.93,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income	-	(1.84%)	199.27%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":-0.93,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

EPS (Diluted)	-	(49.57%)	(58.60%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]

	Dec '22	Dec '23
Total Assets
Current Assets	3.90M	3.33M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.48,"profit":true}]
Non-current Assets	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Assets	3.90M	3.33M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.48,"profit":true}]

Total Liabilities
Current Liabilities	5.69M	3.94M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":69.27,"profit":true}]
Non-current Liabilities	28.48M	44.41M	[{"date":"2022-12-31","value":64.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	34.17M	48.35M	[{"date":"2022-12-31","value":70.67,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	(32.70M)	(47.39M)	[{"date":"2022-12-31","value":-3269500000,"profit":false},{"date":"2023-12-31","value":-4739400000,"profit":false}]
Other Stockholders' Equity	2.42M	2.38M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.1,"profit":true}]
Total Shareholders' equity	(30.27M)	(45.02M)	[{"date":"2022-12-31","value":-3027200000,"profit":false},{"date":"2023-12-31","value":-4501700000,"profit":false}]

Total Liabilities & Shareholders Equity	3.90M	3.33M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.48,"profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	-	(14.52%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Assets	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Assets	-	(14.52%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	(30.73%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Liabilities	-	55.93%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	41.49%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	44.96%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	(1.90%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Shareholders' equity	-	48.71%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(14.52%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

	Dec '23	Sep '24	Mar '25
Total Assets
Current Assets	3.33M	2.15M	102.18M	[{"date":"2023-12-31","value":3.26,"profit":true},{"date":"2024-09-30","value":2.1,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Non-current Assets	-	314.00K	910.00K	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":34.51,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Total Assets	3.33M	2.46M	103.09M	[{"date":"2023-12-31","value":3.23,"profit":true},{"date":"2024-09-30","value":2.39,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	3.94M	13.77M	7.14M	[{"date":"2023-12-31","value":28.64,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":51.88,"profit":true}]
Non-current Liabilities	44.41M	78.08M	32.08M	[{"date":"2023-12-31","value":56.88,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":41.08,"profit":true}]
Total Liabilities	48.35M	91.84M	39.22M	[{"date":"2023-12-31","value":52.65,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":42.7,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Retained Earnings	(47.39M)	(94.53M)	(126.76M)	[{"date":"2023-12-31","value":-4739400000,"profit":false},{"date":"2024-09-30","value":-9453500000,"profit":false},{"date":"2025-03-31","value":-12675700000,"profit":false}]
Other Stockholders' Equity	2.38M	5.16M	-	[{"date":"2023-12-31","value":46.11,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Total Shareholders' equity	(45.02M)	(89.38M)	63.87M	[{"date":"2023-12-31","value":-70.48,"profit":false},{"date":"2024-09-30","value":-139.93,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	3.33M	2.46M	103.09M	[{"date":"2023-12-31","value":3.23,"profit":true},{"date":"2024-09-30","value":2.39,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

	Dec '23	Sep '24	Mar '25
Total Assets
Current Assets	-	(35.58%)	4659.29%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":-0.76,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Non-current Assets	-	-	189.81%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Total Assets	-	(26.16%)	4089.03%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":-0.64,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	249.21%	(48.12%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-19.31,"profit":false}]
Non-current Liabilities	-	75.81%	(58.92%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-77.71,"profit":false}]
Total Liabilities	-	89.95%	(57.30%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-63.7,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Retained Earnings	-	99.47%	34.08%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":34.27,"profit":true}]
Other Stockholders' Equity	-	116.87%	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Total Shareholders' equity	-	98.55%	(171.46%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-173.99,"profit":false}]

Total Liabilities & Shareholders Equity	-	(26.16%)	4089.03%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":-0.64,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	(9.78M)	(14.13M)	[{"date":"2022-12-31","value":-977900000,"profit":false},{"date":"2023-12-31","value":-1413200000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	12.78M	14.24M	[{"date":"2022-12-31","value":89.73,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	3.00M	110.00K	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":3.67,"profit":true}]

Free Cash Flow
Free Cash Flow	(9.78M)	(14.13M)	[{"date":"2022-12-31","value":-977900000,"profit":false},{"date":"2023-12-31","value":-1413200000,"profit":false}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	-	44.51%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	11.44%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	-	(96.33%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	44.51%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '23	Mar '24	Mar '25
Operating Activities
Net Operating Cash Flow	(4.14M)	(4.52M)	(7.44M)	[{"date":"2023-12-31","value":-413600000,"profit":false},{"date":"2024-03-31","value":-452100000,"profit":false},{"date":"2025-03-31","value":-744100000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	6.86M	6.58M	107.27M	[{"date":"2023-12-31","value":6.39,"profit":true},{"date":"2024-03-31","value":6.13,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Net Change in Cash	2.72M	2.06M	99.83M	[{"date":"2023-12-31","value":2.73,"profit":true},{"date":"2024-03-31","value":2.06,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(4.14M)	(4.52M)	(7.44M)	[{"date":"2023-12-31","value":-413600000,"profit":false},{"date":"2024-03-31","value":-452100000,"profit":false},{"date":"2025-03-31","value":-744100000,"profit":false}]

	Dec '23	Mar '24	Mar '25
Operating Activities
Net Operating Cash Flow	-	9.31%	64.59%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":14.41,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(4.08%)	1530.45%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":-0.27,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Net Change in Cash	-	(24.42%)	4750.63%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":-0.51,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	9.31%	64.59%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":14.41,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	KLRS
Current Ratio	14.31

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	KLRS
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	KLRS
Debt Ratio Lower is generally better. Negative is bad.	0.38
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.62

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	KLRS
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Kalaris Therapeutics, Inc. share price today?

Kalaris Therapeutics, Inc. (KLRS) share price today is $2.96

Can Indians buy Kalaris Therapeutics, Inc. shares?

Yes, Indians can buy shares of Kalaris Therapeutics, Inc. (KLRS) on Vested. To buy Kalaris Therapeutics, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KLRS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Kalaris Therapeutics, Inc. be purchased?

Yes, you can purchase fractional shares of Kalaris Therapeutics, Inc. (KLRS) via the Vested app. You can start investing in Kalaris Therapeutics, Inc. (KLRS) with a minimum investment of $1.

How to invest in Kalaris Therapeutics, Inc. shares from India?

You can invest in shares of Kalaris Therapeutics, Inc. (KLRS) via Vested in three simple steps:

Click on Sign Up or Invest in KLRS stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Kalaris Therapeutics, Inc. shares

What is Kalaris Therapeutics, Inc. 52-week high and low stock price?

The 52-week high price of Kalaris Therapeutics, Inc. (KLRS) is $24.15. The 52-week low price of Kalaris Therapeutics, Inc. (KLRS) is $2.65.

What is Kalaris Therapeutics, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Kalaris Therapeutics, Inc. (KLRS) is 0.00

What is the Market Cap of Kalaris Therapeutics, Inc.?

The market capitalization of Kalaris Therapeutics, Inc. (KLRS) is $52.93M

What is Kalaris Therapeutics, Inc.’s stock symbol?

The stock symbol (or ticker) of Kalaris Therapeutics, Inc. is KLRS